Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABOZANTINIB vs CALCIFEDIOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABOZANTINIB vs CALCIFEDIOL: Safety Overview

Metric CABOZANTINIB CALCIFEDIOL
Total FAERS Reports 3,831 708
Deaths Reported 767 207
Death Rate 20.0% 29.2%
Hospitalizations 2,771 389
Average Patient Age 62.2 yrs 72.9 yrs
% Female Patients 27.5% 57.6%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A OPKO Pharmaceuticals LLC
Route N/A ORAL
Marketing Status None Discontinued